Review
Open access
Aug 2026
Firsekibart for gouty arthritis: a review of clinical efficacy, safety, and therapeutic positioning
Firsekibart provides a single-dose therapeutic paradigm combining rapid analgesia with sustained flare prevention and generally favourable short- to medium-term safety, with no treatment-related serious adverse events reported in the gout trials.
Gao-Yi Yi, Hong-Mei Diao, Qiang Zhou et al.
· The Egyptian Journal of Inte... · 0 citations